Brand Narrative and the Word 'Change'

I’ve yet to come across a brand that doesn’t want to change something.

But — and it’s a big but — change is a word that can mean absolutely nothing.

A quick scan of many brand narratives shows how often it's used.
But from a storytelling strategy perspective, the real questions are:

👉 What do we want to change?
👉 Who do we want to change?

Take Pfizer.
Their goal? To change patients’ lives.

Now look at Johnson & Johnson.
Their ambition? To change the trajectory of health for humanity.

Two big pharma brands.
Two very different storytelling strategies around “change.”

🔍 Opportunity for Pfizer:
This is a brand owning the clinical space — a biotech giant delivering next-gen therapeutics that change the course of disease.

But here’s the challenge:
Pfizer’s focus on “patients” can feel cold, objectifying, even reductionist.
So we must ask: Who is a patient?

🔍 Opportunity for J&J:
J&J is playing at the system level — not changing individuals, but reshaping the systems that shape our health.

But here’s a question:
Is trajectory the right word?
Or does journey feel more human?

In systems-thinking brand narratives, big words can backfire.
They may impress in journals, but miss in public imagination.

💡 Healthcare branding is 15% science and 75% emotion.
The best stories don’t just say “change.” They approach the narrative intentionally.

Can you spot the difference in how these top pharmaceutical brands approach 'change' in their storytelling strategy?Breakthroughs that change  patients’ lives.
 Pfizer.
kehinde bademosiComment